MarketPeel
Insider Trading Intelligence
JT

Jason E. Tester

TARS
DIRECTOR · TARSUS PHARMACEUTICALS, INC. · CIK 0001827272
FILING MIX · LIFETIME62%/38%
BUYS
8
SELLS
5
TOTAL VALUE
$2.75M
COMPANIES
1
ACTIVE SINCE
Oct 2020
HOLDINGS NOW
10,000
AVG SELL PX
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Jason E. Tester, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%-4.79%-1.50%-3.28%-3.28%
14d2+100.00%+10.61%-2.14%+12.75%+12.75%
30d2+100.00%+10.32%+4.20%+6.13%+6.13%
60d2+100.00%+133.95%+7.97%+125.97%+125.97%
90d2+100.00%+99.67%+10.74%+88.93%+88.93%
180d2+100.00%+31.26%+21.83%+9.43%+9.43%
1y2+100.00%+33.99%+33.61%+0.38%+0.38%
2y2+0.00%-25.32%+9.55%-34.87%-34.87%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARS · 10,000 shares · as of Jun 15, 2021
0480,233960,4671,440,7001,920,9332021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
FLOW · 8 buys / 5 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 15, 2021Jun 17, 2021
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
21,57521,575Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
21,5750Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
1,434,7900Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
3,6980Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
245,9661,680,756Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
1,434,7901,434,790Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
71,4270Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
168,750$16.00$2.70M1,920,933Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
3,125$16.00$50.0K28,398Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
3,69825,273Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
245,9660Oct 20, 2020Oct 20, 2020
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
71,4271,752,183Oct 20, 2020Oct 20, 2020
Other insiders · TARS
Loading peer insiders…
About this filer
CIK 0001827272
ROLE
Director
PRIMARY
TARS
COMPANIES
1
ACTIVE SINCE
Oct 2020
MARKETPEEL · /INSIDER/0001827272DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback